The reduced expression of TPM2 in PCa patient tumor tissues is significantly correlated with a less favorable prognosis, suggesting that downregulation of TPM2 predicts poor outcomes for PCa patients (Varisli, 2013). Here, TPM2 is linked to neoplasm.